You’ve probably heard of Ozempic or Wegovy. These are the injectable drugs that have become household names for weight loss and diabetes. Now, researchers are investigating whether these medications ...
Novo Nordisk, the maker of Ozempic, is suing Eli Lilly over advertisements comparing some of their biggest-selling drugs. The ads compare Lilly’s Zepbound with Novo’s Wegovy, and Novo argues they give ...
Competition between two of the biggest names in weight-loss drugs has moved from pharmacies and television screens into the courtroom.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results